Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor-Reference-Cited by-同舟云学术

Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor

Published:2023-08 Issue: Volume:256 Page:115448
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhi Yanle,Li Hongmei,Yang Pei,Jin Qiaomei,Yao Chao,Li Baoquan,Ling Jun,Guo Hao,Li Tonghui,Jin Jianlin,Wang Yue,Chen Yadong,Lu Tao,Lu Shuai^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference21 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

2. FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myeloid leukemia;Novatcheva;Clin. Lymphoma, Myeloma & Leukemia,2022

3. Expression and signal transduction of the FLT3 tyrosine kinase receptor;Rosnet;Acta Haematol.,1996

4. Targeting FLT3 mutations in AML: review of current knowledge and evidence;Daver;Leukemia,2019

5. FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions;Antar;Leukemia,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PT-Finder: A multi-modal neural network approach to target identification;Computers in Biology and Medicine;2024-05

2. Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations;European Journal of Medicinal Chemistry;2024-03

3. An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L;European Journal of Medicinal Chemistry;2024-01